Pathology

AALL1331 (intermediate- and high-risk relapse)

Study

AALL1331 (low-risk relapse)

Study

AALL1731

Study

Abnormal uterine bleeding

Disease

ACORN

Study

ACOSOG Z0011 (10-year survival)

Study

ACOSOG Z0011 (5-year survival)

Study

ACT HIV

Study

Actinic keratosis

Disease

Acute interstitial nephritis

Disease

Acute lymphoblastic leukemia

Disease

Acute myeloid leukemia

Disease

Acute pericarditis

Disease

Acute promyelocytic leukemia

Disease

ADAURA

Study

ADIGE

Study

Adjuvant HAIC with FOLFOX for HCC

Study

Adrenal incidentaloma

Disease

Adrenocortical carcinoma

Disease

ADRIATIC

Study

ADVOCATE

Study

AEGEAN

Study

Age Trial

Study

AIRTRIP

Study

Alcohol-related liver disease

Disease

ALEX

Study

ALEXANDRA/IMpassion030

Study

ALIGN

Study

Alliance A011502

Study

Allied disorders of Hirschsprung's disease

Disease

ALMS

Study

AMBASSADOR

Study

AMPLIFY (acalabrutinib/venetoclax)

Study

AMPLIFY (acalabrutinib/venetoclax/obinutuzumab)

Study

Ampullary cancer

Disease

ANAHYDRET

Study

Anal cancer

Disease

ANCHOR

Study

ANDROMEDA

Study

Anogenital warts

Disease

Anti-glomerular basement membrane disease

Disease

AntibioCor

Study

ANTICIPUSC

Study

Antimicrobial prophylaxis in pancreatoduodenectomy

Study

Appendiceal neoplasm

Disease

APPLAUSE-IgAN

Study

AQUILA

Study

ARASENS

Study

ARES (aspirin BID vs. aspirin OD)

Study

ARES (aspirin TID vs. aspirin OD)

Study

Arrhythmogenic right ventricular cardiomyopathy

Disease

ASC4FIRST

Study

ASCEMBL

Study

ASCEND (pirfenidone)

Study

ATLAS (tamoxifen)

Study

Atrophic gastritis

Disease

ATTR-ACT

Study

ATTRibute-CM

Study

AURORA 2

Study

Autoimmune hepatitis

Disease

AZA-001

Study